RAPP
Rapport Therapeutics, Inc. Common Stock
Mentions (24Hr)
-100.00% Today
Reddit Posts
Mentions
I was so risk adverse going into today, I should have yolo'd. Oh well, looks good going forward as well! >William Blair analyst Myles Minter [described the results as "unprecedented."](https://www.investors.com/news/technology/xenon-pharmaceuticals-focal-onset-seizures-treatment/) >"This blows away our bull case expectations of (greater than or equal to) 30% placebo-normalized improvement described in our data preview," he said in a report. "Investors were debating if the bar should be 25% or 30% on a placebo-normalized basis and the data clearly blasts through both." >Not only does this set Xenon Pharmaceuticals up well to potentially compete with Praxis Precision Medicines (PRAX) and Rapport Therapeutics (RAPP), it could also set Xenon on the path to an acquisition, analysts said. >Johnson & Johnson (JNJ) spent $14.6 billion to buy neuroscience-focused Intra-Cellular Therapies in 2025. Jazz Pharmaceuticals (JAZZ) bought GW Pharma and its seizure drug for $7.2 billion in 2021. >**In premarket trades, Xenon Pharmaceuticals shares catapulted more than 43% to 60.10.**
Yeah, the “$100 at a time” goal isn’t a realistic one. I did the same thing when I first got into options trading 5 years ago. The real goal should be to be profitable more often than not, learn to determine when to close a losing position to mitigate losses, and especially, learning to close a profitable position and not be greedy. And learning how to plan your trades so you already have a determined entry and exit point based on the price action of the stock, understanding how the stock tends to move (as in what days of the week it typically moves up or down), etc. in my opinion, a lot of that stuff is really only learned through experience I turned $200 into $1200 in a month using put credit spreads on NVDA doing this, and $200 into $1500 with naked puts on RAPP recently in 3 days. Though that one was obviously just a calculated gamble lol